Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment
Crossref DOI link: https://doi.org/10.1371/journal.pone.0179095
Published Online: 2017-06-06
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Paužuolis, Mindaugas http://orcid.org/0000-0003-1876-8176
Eich, Torsten
Burman, Joachim http://orcid.org/0000-0002-7045-1806
Version of Record valid from 2017-06-06